Project Grant R21MH142385
Award Date 6/1/26
Completion Date 5/31/28
Dollars Obligated $462K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10461, USA
Similar Awards
- Federal Project Grant Award Summary Albert Einstein College of Medicine received a $756,000 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning March 15, 2026, with an ultimate completion date of February 28, 2029. This pilot study addresses the critical need to improve pre-exposure prophylaxis (PrEP) engagement among people who use substances (PWUS), an HIV priority population with historically low PrEP...
- Summary The National Institute of Mental Health awarded Columbia University's Health Sciences Division a $751,490 Project Grant under the Mental Health Research Grants program (CFDA 93.242) for the three-year period April 1, 2026 through March 31, 2029. The project will develop and evaluate a comprehensive resource package designed to accelerate adoption of clinical decision support (CDS) tools for long-acting injectable (LAI) HIV prevention and treatment medications across U.S. HIV clinics. The...
- Federal Grant Award Summary The National Institute of Mental Health awarded the University of North Carolina at Chapel Hill $1,369,530 under the Mental Health Research Grants program (CFDA 93.242) on September 23, 2025, for a three-year project period concluding September 22, 2028. The award supports the "RELAI" (Reaching Persons with HIV Who Are Out of Care Through Expedited Access to Long-Acting Injectable Antiretroviral Therapy) study, which evaluates field-based delivery of...
- Federal Grant Award Summary The University of Chicago received a $200,000 project grant awarded July 7, 2025, through the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242) to develop and test the PHARM ART (Pharmacy Technicians to Advance the Reach of Modern Antiretroviral Therapy) model. This implementation science research project will adapt and evaluate a pharmacy technician-based delivery model for long-acting injectable...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded Icahn School of Medicine at Mount Sinai a $3.6M Project Grant under the Mental Health Research Grants program (CFDA 93.242) on September 22, 2025, with a completion date of September 21, 2029. This research project, titled "Targeting the NLRP3 Inflammasome to Mitigate Neuroinflammation and HIV Persistence in the CNS: Mechanisms and Therapeutic Strategies," investigates the role of the NLRP3...
- Federal Project Grant Summary The National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), awarded a $223,550 Project Grant to Icahn School of Medicine at Mount Sinai effective June 9, 2025, with completion targeted for June 8, 2027. The research initiative focuses on clinical and implementation outcomes of a point-of-care sexually transmitted infection (STI) testing strategy designed to improve HIV prevention service delivery in adolescents. The...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded J. David Gladstone Institutes a Project Grant totaling $2,177,199 under the Mental Health Research Grants program (CFDA 93.242), effective September 1, 2025, through August 31, 2027. This two-phase, milestone-driven research initiative aims to develop and validate a novel humanized microglia-neural cell (HUMGN) mouse model that incorporates human microglia, neurons, and astrocytes differentiated from induced...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Washington a $729,551 Project Grant (CFDA 93.242 – Mental Health Research Grants) on May 4, 2026, with an ultimate completion date of February 28, 2031. This implementation science project, titled "Pharmacies in HIV Prevention: Fellowship, Fundamentals, and Sustainable Finances," addresses barriers to widespread adoption of HIV pre-exposure prophylaxis (PrEP) through pharmacy-based...
- Federal Grant Award Summary New York Blood Center, Inc. received a $485,131 Project Grant from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242) effective September 22, 2025, with completion targeted for September 21, 2027. The award funds research investigating the influence of social networks on HIV (Human Immunodeficiency Virus) testing and PrEP (Pre-Exposure Prophylaxis) care utilization among young Latin American gay, bisexual, and other...
- Federal Grant Award Summary The National Institute of Mental Health awarded Columbia University's Health Sciences Division a $149,190 Project Grant (CFDA 93.242: Mental Health Research Grants) on August 9, 2026, with a completion date of February 29, 2028. This research initiative will develop and validate improved epidemiological methods to characterize Pre-Exposure Prophylaxis (PrEP) need and utilization in Eswatini, where adult HIV prevalence exceeds 31% and national incidence remains the...